BRPI0810881A2 - Uso de bactérias do ácido lático selecionadas para redução da aterosclerose - Google Patents
Uso de bactérias do ácido lático selecionadas para redução da ateroscleroseInfo
- Publication number
- BRPI0810881A2 BRPI0810881A2 BRPI0810881-1A2A BRPI0810881A BRPI0810881A2 BR PI0810881 A2 BRPI0810881 A2 BR PI0810881A2 BR PI0810881 A BRPI0810881 A BR PI0810881A BR PI0810881 A2 BRPI0810881 A2 BR PI0810881A2
- Authority
- BR
- Brazil
- Prior art keywords
- lactic acid
- acid bacteria
- selected lactic
- reduce atherosclerosis
- atherosclerosis
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title 2
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 241000894006 Bacteria Species 0.000 title 1
- 235000014655 lactic acid Nutrition 0.000 title 1
- 239000004310 lactic acid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/786,356 US20080254011A1 (en) | 2007-04-11 | 2007-04-11 | Use of selected lactic acid bacteria for reducing atherosclerosis |
PCT/SE2008/050248 WO2008127180A1 (en) | 2007-04-11 | 2008-03-05 | Use of selected lactic acid bacteria for reducing atherosclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0810881A2 true BRPI0810881A2 (pt) | 2014-10-21 |
Family
ID=39853915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0810881-1A2A BRPI0810881A2 (pt) | 2007-04-11 | 2008-03-05 | Uso de bactérias do ácido lático selecionadas para redução da aterosclerose |
Country Status (11)
Country | Link |
---|---|
US (2) | US20080254011A1 (pt) |
EP (1) | EP2136824A4 (pt) |
JP (1) | JP2010523144A (pt) |
KR (1) | KR20100015371A (pt) |
CN (1) | CN101702881A (pt) |
AU (1) | AU2008239833A1 (pt) |
BR (1) | BRPI0810881A2 (pt) |
CA (1) | CA2683912A1 (pt) |
RU (1) | RU2490019C2 (pt) |
UA (1) | UA101316C2 (pt) |
WO (1) | WO2008127180A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2419114T4 (da) * | 2009-05-01 | 2019-05-27 | Uas Laboratories Llc | Bakteriesammensætninger til profylakse og behandling af degenerative sygdomme |
US20110293710A1 (en) * | 2010-02-02 | 2011-12-01 | Delphine Saulnier | Immunomodulatory properties of lactobacillus strains |
RU2460776C9 (ru) * | 2011-04-21 | 2012-11-10 | Общество с ограниченной ответственностью "Бифилюкс" | Штамм lactobacillus acidophilus, используемый для получения продукции, содержащей лактобактерии |
US20130022586A1 (en) * | 2011-07-21 | 2013-01-24 | James Versalovic | Production and use of bacterial histamine |
EP2785878B1 (en) * | 2011-11-30 | 2016-08-31 | Compagnie Gervais Danone | Reuterin-producing lactobacillus brevis |
US20130251829A1 (en) * | 2012-03-23 | 2013-09-26 | Mead Johnson Nutrition Company | Probiotic derived non-viable material for infection prevention and treatment |
US20150150917A1 (en) * | 2012-06-04 | 2015-06-04 | Michigan State University | Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals |
US20150299776A1 (en) * | 2012-10-03 | 2015-10-22 | Metabogen Ab | Identification of a Person having Risk for Atherosclerosis and Associated Disease by the Person's Gut Microbiome and the Prevention of such Diseases |
US10314916B2 (en) * | 2013-06-11 | 2019-06-11 | House Wellness Foods Corporation | Carrier for delivery of substance to phagocytes |
GB201319531D0 (en) | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition & methods of screening |
GB201319539D0 (en) * | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition & methods of screening |
GB201319538D0 (en) * | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition |
GB201319540D0 (en) | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition |
CA2966074A1 (en) | 2013-11-05 | 2016-05-12 | Optibiotix Limited | Prebiotic composition and its method of production |
CN105062933A (zh) * | 2015-09-11 | 2015-11-18 | 北京博锦元生物科技有限公司 | 一种罗伊氏乳杆菌及其应用 |
JP6986856B2 (ja) * | 2016-05-10 | 2021-12-22 | 協同乳業株式会社 | トリメチルアミンを産生し難い腸内菌叢を形成するためのプロバイオティクス組成物および方法 |
CN106434427A (zh) * | 2016-08-29 | 2017-02-22 | 中国疾病预防控制中心传染病预防控制所 | 乳酸杆菌益生菌cgmcc no.12421及在制备降脂药物中的应用 |
CN112236155A (zh) * | 2018-05-31 | 2021-01-15 | 深圳华大生命科学研究院 | 一种组合物及其应用 |
CN109453152B (zh) * | 2018-11-23 | 2020-10-27 | 西安交通大学 | 一种改善主动脉内皮细胞功能的药物及其应用 |
US20230146454A1 (en) * | 2019-09-26 | 2023-05-11 | Precisionbiotics Group Limited | Lactobacillus reuteri |
CN111560330B (zh) * | 2020-05-12 | 2022-04-26 | 天津科技大学 | 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用 |
CN111588021A (zh) * | 2020-05-25 | 2020-08-28 | 北京科拓恒通生物技术股份有限公司 | 一株可缓解和治疗冠心病的乳双歧杆菌Probio-M8及其应用 |
CN113249249A (zh) * | 2021-04-29 | 2021-08-13 | 南昌大学 | 一种具有缓解动脉粥样硬化功效的植物乳杆菌zdy04 |
CN114410533A (zh) * | 2022-01-27 | 2022-04-29 | 江南大学 | 罗伊氏乳杆菌ccfm1040在缓解、预防动脉粥样硬化中的应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5413960A (en) * | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
US5458875A (en) * | 1990-06-15 | 1995-10-17 | Biogaia Ab | In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry |
US5534253A (en) * | 1995-06-07 | 1996-07-09 | Biogaia Ab | Method of treating enteropathogenic bacterial infections in poultry |
US5837238A (en) * | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
JP3400282B2 (ja) * | 1997-02-21 | 2003-04-28 | 株式会社ヤクルト本社 | 脂質代謝改善剤およびそれを含有する食品 |
SE510753C2 (sv) * | 1997-08-05 | 1999-06-21 | Probi Ab | Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod |
AU770726B2 (en) * | 1998-10-20 | 2004-02-26 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Use of a cytokine-producing lactococcus strain to treat colitis |
AUPR101600A0 (en) * | 2000-10-25 | 2000-11-16 | Atheromastat Pty Ltd | Compositions and methods for diagnosis and treatment of cardiovascular disorders |
AUPS194902A0 (en) * | 2002-04-24 | 2002-06-06 | Atheromastat Pty Ltd | Compositions and methods for diagnosis and treatment of cardiovascular disorders |
EP2298810A3 (en) * | 2002-07-19 | 2011-08-03 | Abbott Biotechnology Ltd | Treatment of TNF alpha related disorders |
US7105336B2 (en) * | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
TWI241912B (en) * | 2002-10-30 | 2005-10-21 | Food Industry Res & Dev Inst | Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
US6872565B2 (en) * | 2003-01-29 | 2005-03-29 | Biogaia Ab | Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries |
JP2005336159A (ja) * | 2004-04-28 | 2005-12-08 | Univ Kurume | Nadphオキシダーゼ活性を抑制する色素上皮由来因子の新規治療用途 |
GB0424552D0 (en) * | 2004-11-05 | 2004-12-08 | Cambridge Theranostics Ltd | Methods and means |
US7344867B2 (en) * | 2005-04-15 | 2008-03-18 | Eamonn Connolly | Selection and use of lactic acid bacteria for reducing inflammation in mammals |
WO2008028300A1 (en) * | 2006-09-07 | 2008-03-13 | Mcgill University | Oral polymeric membrane feruloyl esterase producing bacteria formulation |
-
2007
- 2007-04-11 US US11/786,356 patent/US20080254011A1/en not_active Abandoned
-
2008
- 2008-03-05 AU AU2008239833A patent/AU2008239833A1/en not_active Abandoned
- 2008-03-05 UA UAA200911456A patent/UA101316C2/ru unknown
- 2008-03-05 CA CA002683912A patent/CA2683912A1/en not_active Abandoned
- 2008-03-05 EP EP08724195A patent/EP2136824A4/en not_active Withdrawn
- 2008-03-05 BR BRPI0810881-1A2A patent/BRPI0810881A2/pt not_active IP Right Cessation
- 2008-03-05 CN CN200880011696A patent/CN101702881A/zh active Pending
- 2008-03-05 RU RU2009141617/15A patent/RU2490019C2/ru not_active IP Right Cessation
- 2008-03-05 KR KR1020097020740A patent/KR20100015371A/ko not_active Application Discontinuation
- 2008-03-05 WO PCT/SE2008/050248 patent/WO2008127180A1/en active Application Filing
- 2008-03-05 JP JP2010502970A patent/JP2010523144A/ja active Pending
-
2010
- 2010-11-18 US US12/927,539 patent/US20110081328A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110081328A1 (en) | 2011-04-07 |
RU2490019C2 (ru) | 2013-08-20 |
KR20100015371A (ko) | 2010-02-12 |
WO2008127180A1 (en) | 2008-10-23 |
AU2008239833A2 (en) | 2009-11-26 |
CA2683912A1 (en) | 2008-10-23 |
US20080254011A1 (en) | 2008-10-16 |
EP2136824A4 (en) | 2010-12-08 |
CN101702881A (zh) | 2010-05-05 |
AU2008239833A1 (en) | 2008-10-23 |
JP2010523144A (ja) | 2010-07-15 |
RU2009141617A (ru) | 2011-05-20 |
EP2136824A1 (en) | 2009-12-30 |
UA101316C2 (ru) | 2013-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0810881A2 (pt) | Uso de bactérias do ácido lático selecionadas para redução da aterosclerose | |
BRPI0710944A2 (pt) | uso de bactéria selecionada de ácido lático para reduzir cólicas infantis | |
BRPI1013829A2 (pt) | composições e métodos para fermentação de biomassa | |
BRPI1009920A2 (pt) | composições bacterianas para profilaxina e tratamento de doença degenerativa. | |
BRPI0911290A2 (pt) | âncora universal para ligar objetos ao tecido ósseo | |
BRPI0815407A2 (pt) | Composições e métodos para controlar nematódeos | |
BRPI1009982A2 (pt) | composição antimicrobiana hidratante | |
ES2397671T8 (es) | Procedimiento para preparar voriconazol | |
BRPI0920670A8 (pt) | composição nutritiva para promover o desenvolvimento e crescimento sadios | |
FR2942627B1 (fr) | Composition de graisse | |
BRPI0908087A2 (pt) | Composições e métodos para implante de tecido adipose e produtos de tecido adiposo | |
BRPI0913086A2 (pt) | Composições antimicrobianas e métodos de uso | |
BRPI0808522A2 (pt) | Uso de lactobacilus plantarum para aumentar diversidade bacterial | |
BR112012005680A2 (pt) | composição de higiene pessoal | |
FI20096058A0 (fi) | Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä | |
BR112013002123A2 (pt) | composição ácida adesiva para limpeza de sanitários e/ou desodorização | |
BRPI1008253A2 (pt) | Metoso para tratar biomassa | |
BRPI1006024A2 (pt) | composição cosmética emulsificada | |
BRPI0917172A2 (pt) | Composição bacteriana | |
BRPI1006861A2 (pt) | métodos para isolar bactérias | |
BRPI0910359A2 (pt) | método para inibir o crescimento de microorganismos e composição biocida | |
BRPI0912687A2 (pt) | uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia | |
BRPI0912099A2 (pt) | preparação percutaneamente absorvível | |
BRPI0816290A2 (pt) | Isolamento de micro-organismos formadores de péletes | |
BR112012015447A2 (pt) | composição tópica para aplicação cutânea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 35/747 (2015.01), A23L 33/135 (2016.01), A61P |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |